These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7501933)

  • 1. [Role of ranitidine in the treatment and prevention of NSAID-induced digestive lesions].
    Bommelaer G
    Rev Med Suisse Romande; 1995 Oct; 115(10):799-802. PubMed ID: 7501933
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Chan FK; Sung JJ
    N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
    [No Abstract]   [Full Text] [Related]  

  • 3. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healing and prevention of NSAID-associated ulcer disease: is seeing believing?
    Fendrick AM; Scheiman JM
    Am J Gastroenterol; 1998 Dec; 93(12):2628-9. PubMed ID: 9860450
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S; Newton WP
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of misoprostol in prevention of gastric disease from nonsteroidal anti-inflammatory drugs in oral-maxillofacial surgery].
    Bocca M; Giordano M; Del Pizzo M; Nelken A; Ghiggia M; Pomatto E
    Minerva Ortognatod; 1990; 8(2):139-41. PubMed ID: 2126183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
    MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-steroidal antirheumatic agents and misoprostol].
    Fritsch WP
    Dtsch Med Wochenschr; 1987 Nov; 112(47):1840. PubMed ID: 3119306
    [No Abstract]   [Full Text] [Related]  

  • 9. Misoprostol and NSAID ulcers.
    Isaacs P
    Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
    Vakhrushev IaM; Loshchakova OIu
    Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper gastrointestinal complications related to non-steroidal anti-inflammatory drugs--what have we achieved so far?
    Wong VW; Leong RW; Chan FK
    Dig Liver Dis; 2004 Jan; 36(1):1-3. PubMed ID: 14971808
    [No Abstract]   [Full Text] [Related]  

  • 13. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis.
    Mulberg AE; Linz C; Bern E; Tucker L; Verhave M; Grand RJ
    J Pediatr; 1993 Apr; 122(4):647-9. PubMed ID: 8463919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to: Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
    Gitlin N; Weaver AL
    Int J Clin Pract; 2006 May; 60(5):609-10; author reply 610-11. PubMed ID: 16700865
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 20. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.